KOCH KEVIN · President and CEO at Edgewise Therapeutics, Inc. · 47d agono track record yet
Sold 17,971 @ $43.68 avg · $785,042 · 2026-08-12
Form 4: KOCH KEVIN sold EWTX
KOCH KEVIN (President and CEO at Edgewise Therapeutics, Inc.) reported an open-market sale of 17,971 shares of EWTX at an average $43.68, roughly $785,042, in a Form 4 filed 2026-08-14.
At post $44.17Now $45.32+2.6% since postedas of Sep 18, 4:30 PM ET
1d—
3d-0.3%
1w+0.0%
1m+0.5%
3m—
6m—
1y—